Search Results - "de Boer, Wink A"

Refine Results
  1. 1

    Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial by van Kerkhoven, Lieke A.S, Laheij, Robert J.F, Aparicio, Nives, De Boer, Wink A, Van Den Hazel, Sven, Tan, Adriaan C.I.T.L, Witteman, Ben J.M, Jansen, Jan B.M.J

    Published in Clinical gastroenterology and hepatology (01-07-2008)
    “…Background & Aims: Antidepressants could be effective in the treatment of functional gastrointestinal disorders through their anticholinergic and…”
    Get full text
    Journal Article
  2. 2

    Eradication therapy should be different for dyspeptic patients than for ulcer patients by de Boer, Wink A

    “…Physicians should try to achieve an optimal cure rate with their initial Helicobacter pylori eradication therapy. Most physicians use the same treatment in all…”
    Get full text
    Journal Article
  3. 3

    Eradication of Helicobacter pylori Restores Glutathione S‐Transferase Activity and Glutathione Levels in Antral Mucosa by Oijen, Arnoud H. A. M., Verhulst, Marie‐Louise, Roelofs, Hennie M. J., Peters, Wilbert H. M., Boer, Wink A., Jansen, Jan B. M. J.

    Published in Cancer science (01-12-2001)
    “…Glutathione S‐transferases (GST) and glutathione peroxidases (GPO) are important in detoxification. GST activity in the mucosa of the gastrointestinal tract is…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis? by de Boer, Wink A, Tytgat, Guido N. J

    “…Physicians should try to reach an optimal cure rate with initial anti-Helicobacter therapy. Helicobacter pylori infection in patients with peptic ulcer disease…”
    Get full text
    Journal Article
  6. 6

    A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule by de Boer, Wink A, van Etten, Ruud J.X.M, Schneeberger, Peter M, Tytgat, Guido N.J

    Published in The American journal of gastroenterology (01-03-2000)
    “…OBJECTIVE: In this pilot study we investigated the efficacy and tolerability of a new monocapsule that contains a bismuth compound, tetracycline, and…”
    Get full text
    Journal Article
  7. 7

    Diagnostic performance of biopsy-based methods for determination of Helicobacter pylori infection without a reference standard by Laheij, Robert J.F, de Boer, Wink A, Jansen, Jan B.M.J, van Lier, Henk J.J, Sneeberger, Peter M, Verbeek, Andre L.M

    Published in Journal of clinical epidemiology (01-07-2000)
    “…Endoscopic biopsy-based tests are considered to be the reference method for diagnosing Helicobacter pylori infection and monitoring antibiotic treatment, but…”
    Get full text
    Journal Article
  8. 8

    Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication by Kuipers, Ernst J, Janssen, Marcel JR, de Boer, Wink A

    Published in Current opinion in pharmacology (01-10-2003)
    “…The discovery of Helicobacter pylori has had a major clinical impact. Clinical research is now focused on the role of H. pylori and H. pylori eradication in…”
    Get full text
    Journal Article
  9. 9

    Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study by de Boer, W A, Driessen, W M, Jansz, A R, Tytgat, G N

    “…To assess the efficacy and side-effect profile of two currently advocated treatment regimens for eradicating Helicobacter pylori. A randomized, controlled,…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease by Lai, Jonathan YL, de Grauw, Wim JC, de Boer, Wink A

    Published in Family practice (01-10-1999)
    “…Background. Few patients with a history of peptic ulcer are treated by their GP for H. pylori infection, even though theoretical evidence supports such an…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Disappearance of mesenteric lymphadenopathy with gluten-free diet in celiac sprue by de Boer, W A, Maas, M, Tytgat, G N

    Published in Journal of clinical gastroenterology (01-06-1993)
    “…In an adult patient with untreated celiac sprue, mesenteric lymphadenopathy was detected by computerized tomography (CT). Although malignant lymphoma was…”
    Get more information
    Journal Article
  15. 15

    pH or Hp first? Considerations in the revised Dutch College of General Practitioners' (NHG) practice guideline 'Gastric Symptoms' by de Boer, Wink A

    “…Considerations in the revised Dutch College of General Practitioners' (NHG) practice guideline 'Gastric Symptoms': The NHG practice guideline 'Gastric…”
    Get more information
    Journal Article
  16. 16

    Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance by Graham, D Y, de Boer, W A, Tytgat, G N

    Published in The American journal of gastroenterology (01-06-1996)
    “…The development of effective therapies for the treatment of Helicobacter pylori infection has been a long and arduous process. There is considerable confusion…”
    Get more information
    Journal Article
  17. 17
  18. 18

    A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule by de Boer, W A

    Published in Expert opinion on investigational drugs (01-08-2001)
    “…Helicobacter pylori infection causes peptic ulcer disease and must be regarded as a serious infectious disease. Over the past two decades treatment of the…”
    Get more information
    Journal Article
  19. 19

    Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection by de Boer, W A

    “…Bismuth triple therapy (bismuth compound, metronidazole and tetracycline) is the oldest effective regimen to cure Helicobacter pylori infection. When…”
    Get more information
    Journal Article
  20. 20

    How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint by de Boer, W A, Tytgat, G N

    “…Peptic ulcer disease is an infectious disease. Only antibiotic regimens that achieve a 90% cure should be used to treat this infection. Antimicrobial…”
    Get more information
    Journal Article